معرفی
Vincent Cuminetti is a Researcher at the University of Oslo's Institute of Clinical Medicine, affiliated with the Centre for Embryology and Healthy Development (CRESCO) and the Faculty of Medicine. His primary focus is on hematopoietic stem cell niches, metabolic diseases, and oncology. He earned his PhD in 2017 from the University of Toulouse, France, studying adipose tissue's role in metabolic diseases. He joined Dr. Lorena Arranz's Stem Cells Ageing and Cancer group, investigating leukemia pathogenesis and metabolic rewiring in cancers. Notable achievements include a 2023 Nature Communications publication on IL-1 receptor antagonism in myeloproliferation and a 2025 study on bone marrow neuropathy in hematologic malignancies.
Education:
- PhD in Biomedical Sciences, University of Toulouse, France (2017)
Research Interests:
- Leukemia stem cell biology and niche interactions
- Metabolic pathways in AML progression
- Role of adipose tissue in hematopoiesis
- Cytokine signaling in immune dysregulation
Key Publications Trends: Recent work emphasizes AML pathogenesis (2022–2025), bone marrow microenvironment dynamics, and metabolic reprogramming in cancer. Studies often bridge basic biology with translational implications for therapy development.
Labs/Teams: Active member of the Stem Cells, Ageing and Cancer research group at the Institute of Clinical Medicine, collaborating on projects involving stromal cell interactions and oncometabolite signaling.
